-
Study aim
-
To determine the effect of acupressure on physical and psychological outcomes in patients with multiple sclerosis.
-
Design
-
A single-blind, parallel-group, randomized controlled trial with a block randomization design (block size of 4). The target sample size is 70 participants (35 per group). Randomization will be stratified by age at diagnosis and gender. Allocation concealment will be performed using sequentially numbered, sealed opaque envelopes.
-
Settings and conduct
-
Eligible patients will be recruited and randomly allocated to either the intervention or control group. The intervention group will receive acupressure training in a face-to-face session and perform the technique at home for 4 weeks, with follow-up via social network (Soroush app) or telephone calls. Outcomes (depression, anxiety, fatigue, sleep quality, and quality of life) will be assessed using validated questionnaires (Beck Depression Inventory, Spielberger State-Trait Anxiety Inventory, Fatigue Severity Scale, Pittsburgh Sleep Quality Index, and SF-36) at baseline and immediately after the 4-week intervention period.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Age 18-50 years; confirmed diagnosis of MS for at least one year;...
Exclusion criteria: Inconsistent completion of acupressure sessions;...
-
Intervention groups
-
Intervention group: Patients perform acupressure on three acupoints (HT-7/Shenmen, Ki-3, and Yintang/Third Eye) for 4 weeks, three times per week
Control group: Patients receive no acupressure intervention and continue their routine care.
-
Main outcome variables
-
Mean change in depression score (Beck Depression Inventory)
Mean change in anxiety score (Spielberger State-Trait Anxiety Inventory)
Mean change in fatigue score (Fatigue Severity Scale)
Mean change in sleep quality score (Pittsburgh Sleep Quality Index)
Mean change in quality of life score (SF-36 Questionnaire)